Clinical Trials

A Phase I, Open-Label, Multinational, Multicenter, Dose Escalation and Expansion Study of BH3120 in Patients with Advanced or Metastatic Solid Tumors

ClinicalTrials.gov Identifier

ClinicalTrials.gov registration not required

Principal Investigator

John Sarantopoulos MD

For more information about this study
View Details

About This Study

To evaluate the safety and tolerability of BH3120 administered intravenously (IV) in subjects with advanced or metastatic solid tumors.